Silo Wellness Is Headed Up By A Management Team That Has Been Ahead of The CurveRevive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 ConfirmCybin Corp. Announces Reverse Take-Over Transaction and the Engagement of Stifel GMP and Eight Capital to Co-Lead ConcurHAVN Life Sciences Continues To Execute On Growth Initiatives Ahead Of Its Upcoming Public ListingMindMed Developing IP For Personalized Psychedelic Assisted TherapiesNuminus announces Clinical Advisory Council to advance integrated wellness modelRritual Announces Dr. Mike Hart as PresidentThe Multi-Billion Dollar Functional Mushroom Market Is Up For GrabsMydecine Innovations Group Bolsters Scientific Advisory Board Adding a Leading Neuroscientist and a Psychopharmacology SField Trip Is Shifting Gears To Expedite IPO ProcessMydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health’s Advanced Digital Telehealth PlatforNew Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical DevelopmentNew Wave Holdings Corp Appoints Dr. Dennis McKenna to Psychedelic Research Advisory BoardChampignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin OutRed Light Holland Announces Closing of Second Tranche of Private PlacementNuminus Wellness Has Big Plans To Scale Operations In The Back Half of 2020 Following A Major License Amendment By HealtMydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical InnovationCybin Corp: A Mushroom Life Sciences Leader In The MakingChampignon Announces Closing of $15 Million Bought Deal Private PlacementNuminus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

Technical420 Site Search

Returned 32 result(s).

Silo Wellness Is Headed Up By A Management Team That Has Been Ahead of The Curve

2020 has been a banner year for the psychedelic therapy market and is a vertical that we have been highly focused on. So far this year, there has been a large increase in the number of companies that are focused on this burgeoning market and this is a trend that…

Cybin Corp. Announces Reverse Take-Over Transaction and the Engagement of Stifel GMP and Eight Capital to Co-Lead Concurent Private Placement of up to $21M

Cybin Corp., a mushroom life sciences company focused on psychedelic medicines and nutraceutical products, is pleased to announce that it has entered into an amalgamation agreement dated June 26, 2020 with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly-owned subsidiary of Clarmin. Completion of the transactions contemplated…

HAVN Life Sciences Continues To Execute On Growth Initiatives Ahead Of Its Upcoming Public Listing

We have seen a substantial increase in interest in psychedelic focused businesses during the last month and this is a trend that our readers need to be aware of. The psychedelic sector has recently come under pressure and we encourage our readers to conduct significant due diligence on companies in…

MindMed Developing IP For Personalized Psychedelic Assisted Therapies

Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, is developing technologies and analytics that seek to personalize psychedelic therapy experiences for a specific patient. The technology aims to optimize the dosing of MDMA, LSD and other psychedelics based on a patient's profile.…

Rritual Announces Dr. Mike Hart as President

Rritual, the premium brand in the emerging functional mushroom market, announced today that Dr. Mike Hart has been named as the President of North America's leading mushroom adaptogens company. Dr. Hart has more than 6 years of experience in plant based therapy, including owning and operating his own family medicine clinic in London, Ontario, Canada where he…

Field Trip Is Shifting Gears To Expedite IPO Process

During the last month, we have noticed a significant increase in activity in the psychedelic sector and this is a trend that has caught our attention. The sector looks similar to the cannabis industry in 2016/2017 as companies are lining up to go public on a stock exchange. Earlier this…

New Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical Development

NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (Frankfurt: 0XM2) (OTC: TRMND), an investment issuer focused on emerging sectors including the psychedelic sector, is pleased to announce that it has welcomed Dr. Carolyn Myers, Ph.D. to provide business strategy and business development consulting services to the Company. Dr. Carolyn…

Cybin Corp: A Mushroom Life Sciences Leader In The Making

Last month, we issued an update on Cybin Corp after having the opportunity to speak with members of the management team. Following our conversation, we felt much more comfortable with the business and want to provide a more in-depth look at the opportunity. Cybin is a life sciences company that…

PharmaDrug Receives Conditional Approval for Grant of Options

PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "PharmaDrug") is pleased to announce that it has received conditional approval from the Canadian Securities Exchange for the previously announced (see press release dated June 2, 2020) grant of 5,000,000 options (the "Options") to Terry Booth. Each Option is exercisable for…

Field Trip Health Is Taking A Diversified Approach To Assisted Psychedelic Therapies

So far this year, we have noticed a significant increase in the amount of interest in the psychedelic therapy market and this is a trend that we are closely following. Following the completion of a few successful reverse takeovers, we have started to see a spike in the number of…

Older Posts »

Search Again

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link